Wells Fargo & Co. (WFC) Reports In-Line Q3 EPS of 72c
Get Alerts WFC Hot Sheet
Price: $89.67 --0%
EPS Growth %: +10.8%
Financial Fact:
Mortgages held for sale: 207M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +10.8%
Financial Fact:
Mortgages held for sale: 207M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Wells Fargo & Co. (NYSE: WFC) reported Q3 EPS of $0.72, in-line with the analyst estimate of $0.72. Revenue for the quarter came in at $19.6 billion versus the consensus estimate of $20.22 billion.
"The economic recovery has been more sluggish and uneven than anyone anticipated,” said Chairman and CEO John Stumpf. “We can’t change the economic environment, yet we have worked hard to control the variables we can – making our products and services more relevant to individuals and businesses, focusing on the customer, making as many loans as possible and growing new relationships – as well as fostering longtime ones. We see the results of this focus in growing cross-sell, deposits, and loans. Customers need a trusted financial partner, especially in challenging economic times. Wells Fargo has proven to be that partner over and over again."
"The economic recovery has been more sluggish and uneven than anyone anticipated,” said Chairman and CEO John Stumpf. “We can’t change the economic environment, yet we have worked hard to control the variables we can – making our products and services more relevant to individuals and businesses, focusing on the customer, making as many loans as possible and growing new relationships – as well as fostering longtime ones. We see the results of this focus in growing cross-sell, deposits, and loans. Customers need a trusted financial partner, especially in challenging economic times. Wells Fargo has proven to be that partner over and over again."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Upgrades Yum! Brands (YUM) to Overweight
- Casey's General Stores (CASY) PT Lowered to $750 at Wells Fargo, 'Buyers of the Weakness'
- Axogen prices $208.7M stock offering to fund BioCircuit acquisition
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share